One size fits all, or do we have to rethink optimal programming in implantable cardioverter-defibrillators implanted for secondary prevention?
Main Authors: | Ivan Cakulev, MD, FHRS, Judith A. Mackall, MD, FHRS |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | Heart Rhythm O2 |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666501820300404 |
Similar Items
-
Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
by: Mohammad-Ali Jazayeri, MD, et al.
Published: (2017-06-01) -
Subcutaneous implantable cardioverter-defibrillator implantation in a patient with bilateral pectoral deep brain stimulators
by: Thor Tejada, MD, et al.
Published: (2018-03-01) -
Oversensing of atrial fibrillatory waves in a subcutaneous implantable cardioverter-defibrillator
by: Ankur A. Karnik, MD, FHRS, FACC, et al.
Published: (2017-04-01) -
Salvage of focally infected implantable cardioverter-defibrillator system by in situ hardware sterilization
by: Robert D. Schaller, DO, FHRS, et al.
Published: (2017-09-01) -
Fibrous encapsulation of defibrillation electrode and elevated high-voltage impedance in patients with a subcutaneous implantable cardioverter-defibrillator
by: Jian-Ming Li, MD, PhD, FHRS, et al.
Published: (2020-03-01)